Literature DB >> 26511488

Anticancer and Cancer Prevention Effects of Piperine-Free Piper nigrum Extract on N-nitrosomethylurea-Induced Mammary Tumorigenesis in Rats.

Somchai Sriwiriyajan1, Aman Tedasen2, Narissara Lailerd3, Pleumjit Boonyaphiphat4, Anupong Nitiruangjarat4, Yan Deng2, Potchanapond Graidist5.   

Abstract

Piper nigrum (P. nigrum) is commonly used in traditional medicine. This current study aimed to investigate the anticancer and cancer preventive activity of a piperine-free P. nigrum extract (PFPE) against breast cancer cells and N-nitrosomethylurea (NMU)-induced mammary tumorigenesis in rats. The cytotoxic effects and the mechanism of action were investigated in breast cancer cells using the MTT assay and Western blot analysis, respectively. An acute toxicity study was conducted according to the Organization for Economic Co-operation and Development guideline. Female Sprague-Dawley rats with NMU-induced mammary tumors were used in preventive and anticancer studies. The results showed that PFPE inhibited the growth of luminal-like breast cancer cells more so than the basal-like ones by induction of apoptosis. In addition, PFPE exhibited greater selectivity against breast cancer cells than colorectal cancer, lung cancer, and neuroblastoma cells. In an acute toxicity study, a single oral administration of PFPE at a dose of 5,000 mg/kg body weight resulted in no mortality and morbidity during a 14-day observation period. For the cancer preventive study, the incidence of tumor-bearing rats was 10% to 20% in rats treated with PFPE. For the anticancer activity study, the growth rate of tumors in the presence of PFPE-treated groups was much slower when compared with the control and vehicle groups. The extract itself caused no changes to the biochemical and hematologic parameters when compared with the control and vehicle groups. In conclusion, PFPE had a low toxicity and a potent antitumor effect on mammary tumorigenesis in rats. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26511488     DOI: 10.1158/1940-6207.CAPR-15-0127

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  6 in total

1.  Multistage Extraction of Star Anise and Black Pepper Derivatives for Antibacterial, Antioxidant, and Anticancer Activity.

Authors:  Helin Li; Xiaoyu Wu; Xin Li; Xiaobing Cao; Yanjun Li; Huaru Cao; Yongzhi Men
Journal:  Front Chem       Date:  2021-05-14       Impact factor: 5.221

2.  Uncoupling genotoxic stress responses from circadian control increases susceptibility to mammary carcinogenesis.

Authors:  Mingzhu Fang; Pamela A Ohman Strickland; Hwan-Goo Kang; Helmut Zarbl
Journal:  Oncotarget       Date:  2017-05-16

Review 3.  Overview of the Anticancer Potential of the "King of Spices" Piper nigrum and Its Main Constituent Piperine.

Authors:  Eleonora Turrini; Piero Sestili; Carmela Fimognari
Journal:  Toxins (Basel)       Date:  2020-11-26       Impact factor: 4.546

4.  Ocimum sanctum, Zingiber officinale, and Piper nigrum extracts and their effects on gut microbiota modulations (prebiotic potential), basal inflammatory markers and lipid levels: oral supplementation study in healthy rats.

Authors:  Narendra Babu Kondapalli; Rajkumar Hemalatha; Satyanarayana Uppala; Srinivas Reddy Yathapu; Shujauddin Mohammed; Mullapudi Venkata Surekha; Ananthan Rajendran; Dinesh Kumar Bharadwaj
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

5.  The attenuation effect of low piperine Piper nigrum extract on doxorubicin-induced toxicity of blood chemical and immunological properties in mammary tumour rats.

Authors:  Jirakrit Saetang; Aman Tedasen; Surasak Sangkhathat; Natnaree Sangkaew; Sirinapa Dokduang; Napat Prompat; Siriporn Taraporn; Potchanapond Graidist
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

Review 6.  Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Sicon Mitra; Uttpal Anand; Niraj Kumar Jha; Mahipal S Shekhawat; Suchismita Chatterjee Saha; Potshangbam Nongdam; Kannan R R Rengasamy; Jarosław Proćków; Abhijit Dey
Journal:  Front Pharmacol       Date:  2022-01-07       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.